Form D — Antares Therapeutics, Inc.
0002059043-25-000001 · filed 2025-03-12
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $40,000,000
- Total sold
- $40,000,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Antares Therapeutics, Inc.
- CIK
- 2059043
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- ONE WINTHROP SQUARE, SUITE 400
BOSTON, MA 02110 - Phone
- 781-288-5760
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Adam Friedman · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Brian Piper · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Andrew Fedder · Executive OfficerBoston, MA Find on LinkedIn ↗
View original on SEC EDGAR.